A standard blood panel is built to answer one question: is there disease present today? A comprehensive panel is built to answer a different one: how is this body actually working, and what is starting to change? The markers are different, and so is what you can do with the answer.
Reviewed by Dr. David Oliak, board-certified surgeon
Updated August 2026
The blood work at an annual physical is designed to detect disease. It is good at that, and it is the right test for that purpose. If your kidneys are failing or your blood sugar is diabetic, a standard panel will find it.
What it is not designed to do is describe how a healthy body is functioning, or show a process that has started but has not yet produced a diagnosis. Those are different questions, and they need different markers.
That is the whole distinction. Not that one panel is better — that they answer different things. A comprehensive panel measures the markers that change early, in the years when a trajectory can still be altered easily.
Most of what goes wrong metabolically begins with insulin resistance, and it begins quietly.
As cells become less responsive to insulin, the pancreas compensates by producing more of it. Blood sugar stays normal — because the body is working harder to keep it normal. That compensation can continue for years. By the time glucose or HbA1c finally rises, the underlying process has been running for a long time.
Fasting insulin measures the compensation itself, which is why it is the single most informative marker on a comprehensive panel and why it is almost never on a routine one. Our fasting insulin page covers it in full.
Alongside it: glucose and HbA1c, which reflect roughly the previous three months. Plus uric acid and GGT, both of which track with metabolic strain.
A standard lipid panel measures how much cholesterol is being carried. That is useful, and it is not the most precise question.
ApoB counts the particles. Each atherogenic particle carries one ApoB molecule, so measuring ApoB counts how many particles are available to deposit into an artery wall, which is closer to the mechanism than measuring the cholesterol inside them. Two people with identical LDL cholesterol can have meaningfully different particle counts.
Lp(a) is largely inherited and rarely tested. It is set mostly by genetics, stays fairly stable through life, and raises cardiovascular risk independently of everything else on the panel. It only needs measuring once, and most people never have.
Homocysteine is measured alongside these as an additional marker. Our ApoB and Lp(a) page covers the cardiovascular markers in detail.
Fatigue, weight change, poor sleep, low mood, low libido, and difficulty maintaining muscle are the symptoms most often written off as getting older. They are also the symptoms of several treatable hormonal changes.
A comprehensive panel measures thyroid properly — TSH with free T4, free T3, and antibodies rather than TSH alone. That is because thyroid disease overlaps almost completely with the perimenopausal transition and with low testosterone, and it is the most commonly missed of the three.
It measures testosterone as total and free, with SHBG, because the free fraction is what tissues use and the two can diverge.
And it measures estradiol and FSH, which matter for women in the transition and for men on testosterone therapy.
hs-CRP is a general marker of inflammation, which sits underneath both how you feel day to day and longer-term cardiovascular risk.
Ferritin measures iron stores. Low ferritin is a common and frequently missed cause of fatigue, particularly in women with heavy perimenopausal bleeding, and it can be low while a standard blood count still looks normal.
Vitamin D and B12 are measured because deficiency is common, produces symptoms that resemble several other conditions, and is straightforward to correct.
None of these is exotic. What is unusual is measuring them together, at the same time, and reading them as one picture.
As a bariatric surgeon I spent twenty years treating the end stage of metabolic disease — severe obesity, diabetes, cirrhosis, cardiovascular disease. Now we intervene at the opposite end of the spectrum: decades earlier, when the changes are still small and still reversible.
These conditions build slowly, and what leads to them is measurable long before anyone feels anything. Finding them at that stage is how you change the direction of a life instead of managing its consequences.
— Dr. David Oliak, board-certified physician and surgeon
There is a version of this that does not help anyone: a long list of numbers, delivered without interpretation, leaving you to work out what matters.
A marker means something different depending on who you are. A ferritin at the bottom of the range means one thing in a man and another in a woman with heavy periods.
A borderline TSH means one thing with thyroid antibodies present and another without them. A rising fasting insulin in someone with a family history of diabetes is a different conversation from the same number in someone without.
This is why the panel is read against your history, your symptoms, and your goals rather than against reference ranges alone, and why the visit is an hour rather than a results printout.
It is also why we treat symptoms and biology rather than treating numbers. The markers guide the plan; they are not the target. Our "normal" versus optimal page covers where that distinction holds up, and where it is overstated.
The plan that comes out of an evaluation is prioritized rather than exhaustive. Most people have several things they could address, and a couple that would make the largest difference.
Foundations first — nutrition, the nutrients you are actually low in, sleep, and resistance training. These do more than they are given credit for, and they cost nothing to start.
Then targeted care where there is a specific goal it serves.
You are not obliged to pursue any of it. Even if you do nothing further, you leave knowing where your health actually stands, which is more than most people have.
Labs describe what your body is doing now. Genetics describe some of why.
A medical-grade genomic analysis, read by a physician and built into your plan, can show inherited tendencies that blood work cannot. It can show how you handle certain nutrients, where inflammation tends to begin, how you are likely to respond to particular medications. It is done once and used for life.
It is optional, and the evaluation stands entirely on its own without it. Our genetic blueprint page covers what it is and what it can and cannot tell you.
This hub links down to each deep-dive in the cluster. Start anywhere.
Why insulin resistance is visible years before blood sugar changes.
Counting particles instead of cholesterol, and the inherited risk most people never test.
Where a result inside the reference range still matters, and where that argument is overstated.
What the evidence supports, and what your labs should decide.
What a medical-grade genomic analysis shows, and what it doesn't.
Let's begin
A comprehensive panel across your metabolic, cardiovascular, hormonal, inflammatory and nutritional health, read with you in an unhurried hour and turned into a plan you can act on. In Brea. To speak with us first, call 714-671-2005.
Fasting insulin: the marker most panels skip
ApoB and Lp(a): better measures of cardiovascular risk
"Normal" versus optimal
The genetic blueprint
Purpose. A standard panel is designed to detect disease that is present, and it does that well.
A comprehensive panel measures how your body is functioning and what is changing. It measures markers like fasting insulin, ApoB, Lp(a), and a full thyroid panel that are not part of routine screening because they are answering a different question.
It measures how hard your pancreas is working to keep your blood sugar normal. As cells become resistant to insulin, the body compensates by producing more, and glucose stays normal for years while that happens. Fasting insulin shows the compensation. It is the earliest widely available signal of a metabolic process that eventually becomes prediabetes.
A lipid panel measures how much cholesterol is being carried; ApoB counts the particles carrying it. Since each atherogenic particle carries one ApoB molecule, it is a closer measure of how many particles could deposit into an artery wall. Two people with the same LDL cholesterol can have different particle counts.
A largely inherited form of cholesterol particle that raises cardiovascular risk independently of the rest of your lipid panel. It stays fairly stable through life, so it only needs measuring once — and most people have never had it measured.
Yes. Fasting insulin, glucose, and the lipid panel all read accurately only from a fasting morning draw.
Often, yes. If you have results from the last three months covering the markers we need, we can use them and skip the draw.
Neither. It is a proactive evaluation of how your body is working, designed to sit alongside your primary care rather than replace it. Where something needs diagnosing or managing conventionally, that is what your physician is for.
Then you know that, which has value on its own. It also redirects the question — if you feel unwell and the panel is unremarkable, the cause is somewhere the panel didn't look, and that is worth pursuing rather than dropping.
